Cory Capps has 20 years of experience as an economist specializing in industrial organization, empirical methods, and antitrust, with a focus on the healthcare industry. He frequently advises and offers expert testimony on behalf of private firms and government agencies on issues relating to market power and competition in the healthcare sector, and he has experience analyzing mergers, joint ventures, price-fixing and market allocation, and exclusionary conduct. Cory Capps has also testified before the US Senate on the competitive implications of vertical mergers in healthcare. Prior to joining Bates White, Cory Capps was a Staff Economist at the Antitrust Division of the US Department of Justice (DOJ), where he concentrated on the analysis of competition in healthcare markets, including merger and civil non-merger investigations of health insurers, hospitals, physicians, nurses, home health agencies, and ambulatory surgery centers. Since 2012, he has been named among International Who’s Who of Competition Economists. In addition to Cory Capps’ broad healthcare experience, he has conducted economic analysis for investigations and cases involving a variety of industries such as airlines, semiconductors, newspapers, online content providers, and agriculture. Cory Capps has also provided economic consulting services to corporations on business and strategy issues. Cory Capps’ academic career includes professorships at the University of Illinois at Urbana-Champaign and at Northwestern University’s Kellogg School of Management. He has published widely in academic journals, including RAND Journal of Economics ; Journal of Economics and Management Strategy ; Journal of Health Economics ; Antitrust Bulletin ; Health Affairs ; and Health Economics, Policy and Law. Cory Capps is currently also a technical advisor to the Health Care Cost Institute.
49
This article has been nominated for the 2020 Antitrust Writing Awards. Click here to learn more about the Antitrust Writing Awards. A STRONGER SECOND COMPETITOR ? ANALYZING THE COMPETITIVE EFFECTS OF THE BETH ISRAEL LAHEY HEALTH TRANSACTION* I. BACKGROUND Could a merger between rival firms (...)
19 avenue Jean Aicard
75011 Paris, France
106 West 32nd Street, Suite 149
New York, NY, 10001, USA
563 Chiswick High Road
W4 3AY London, UK
